18 Jun 2013 10:17
EKF Diagnostics Holdings plc
("EKF" or the "Company" or the "Group")
Director Share Transfer
EKF Diagnostics Holdings plc (AIM: EKF), the growing in-vitro diagnostics company, announces that it received notification on 17 June 2013 from Adam Reynolds, Non-Executive Director of EKF, that he has transferred 100,000 shares of one pence each ("Ordinary Shares") to his daughter as a gift. The transfer took place on 17 June 2013. Adam Reynolds' beneficial interest in the Company following this notification is now 3,176,153 Ordinary Shares, representing 1.16 per cent of the Company's issued share capital.
Enquiries:
EKF Diagnostics Holdings plc | Tel: 029 2071 0570 |
| |
David Evans, Executive Chairman | Mob: 07740 084 452 |
| |
Julian Baines, CEO | Mob: 07788 420 859 |
| |
| |||
Canaccord Genuity Limited | |||
Lucy Tilley / Henry Fitzgerald-O'Connor / Julian Feneley | Tel: 020 7523 8000 | ||
| |||
Walbrook PR Limited | Tel: 020 7933 8780 |
| |
Paul McManus | Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com |
| |
Paul Cornelius | Mob: 07866 384 707 or paul.cornelius@walbrookpr.com |
| |
Ekf Diagnostics (EKF)